Evidence map›Paper›PMID 30525135›Full record

ArticleChemical communications (Cambridge, England)2019

Towards rapid prediction of drug-resistant cancer cell phenotypes: single cell mass spectrometry combined with machine learning.

Renmeng Liu, Genwei Zhang, Zhibo Yang

Abstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Metabolomics of healthy hematopoietic stem cells and leukemic stem cells.Journal of clinical and translational research · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Machine Learning Guides Peptide Nucleic Acid Flow Synthesis and Sequence Design.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Renmeng LiuDepartment of Chemistry and Biochemistry, University of Oklahoma, Norman, Oklahoma 73019, USA. Zhibo.Yang@ou.edu.
Genwei Zhang
Zhibo Yang

Funding

From Single Cells to Tissues: a Novel Mass Spectrometry Approach for BioanalysisR01GM116116 · NIGMS · UNIVERSITY OF OKLAHOMA · PI YANG, ZHIBO · 2015 to 2019
$1.5M
Mass Spectrometry Detection of Drugs in Single Bladder Cancer Cells from PatientsR21CA204706 · NCI · UNIVERSITY OF OKLAHOMA · PI BURGETT, ANTHONY WG · 2016 to 2018
$599k
NCI NIH HHS R21 CA204706NIGMS NIH HHS R01 GM116116
6 · The paper itself

Abstract

Combined single cell mass spectrometry and machine learning methods is demonstrated for the first time to achieve rapid and reliable prediction of the phenotype of unknown single cells based on their metabolomic profiles, with experimental validation. This approach can be potentially applied towards prediction of drug-resistant phenotypes prior to chemotherapy.

Indexed as

Machine LearningPhenotypeDrug Resistance, NeoplasmHumansK562 CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLogistic ModelsMass SpectrometryMetabolomicsNeural Networks, ComputerSingle-Cell AnalysisStochastic Processes

Identifiers

PMID30525135
PMCPMC6640148

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.